Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 846

1.

Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.

Santillan A, Karam AK, Li AJ, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Bristow RE.

Gynecol Oncol. 2007 Mar;104(3):686-90. Epub 2006 Dec 1.

PMID:
17141302
2.

Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.

Fotiou S, Aliki T, Petros Z, Ioanna S, Konstantinos V, Vasiliki M, George C.

Gynecol Oncol. 2009 Aug;114(2):178-82. doi: 10.1016/j.ygyno.2009.04.025. Epub 2009 May 17.

PMID:
19450872
3.

The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study.

Gadducci A, Cosio S, Zola P, Sostegni B, Ferrero AM, Teti G, Cristofani R, Sartori E.

Gynecol Oncol. 2010 Mar;116(3):358-63. doi: 10.1016/j.ygyno.2009.11.008. Epub 2009 Dec 1.

PMID:
19954826
4.

Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer.

Zang RY, Zhang ZY, Li ZT, Chen J, Tang MQ, Liu Q, Cai SM.

J Surg Oncol. 2000 Sep;75(1):24-30.

PMID:
11025458
5.

Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.

Bristow RE, Peiretti M, Gerardi M, Zanagnolo V, Ueda S, Diaz-Montes T, Giuntoli RL 2nd, Maggioni A.

Gynecol Oncol. 2009 Aug;114(2):173-7. doi: 10.1016/j.ygyno.2009.05.004. Epub 2009 May 31.

PMID:
19482344
6.

Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.

Tebes SJ, Sayer RA, Palmer JM, Tebes CC, Martino MA, Hoffman MS.

Gynecol Oncol. 2007 Sep;106(3):482-7. Epub 2007 Jun 27.

PMID:
17590420
7.

Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.

Munkarah A, Levenback C, Wolf JK, Bodurka-Bevers D, Tortolero-Luna G, Morris RT, Gershenson DM.

Gynecol Oncol. 2001 May;81(2):237-41.

PMID:
11330956
8.

Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.

Salani R, Santillan A, Zahurak ML, Giuntoli RL 2nd, Gardner GJ, Armstrong DK, Bristow RE.

Cancer. 2007 Feb 15;109(4):685-91.

9.

The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).

Cheng X, Jiang R, Li ZT, Tang J, Cai SM, Zhang ZY, Tian WJ, Zang RY.

Eur J Surg Oncol. 2009 Oct;35(10):1105-8. doi: 10.1016/j.ejso.2009.03.010. Epub 2009 May 13.

PMID:
19443175
10.

Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study.

Ferrero A, Ditto A, Giorda G, Gadducci A, Greggi S, Daniele A, Fuso L, Panuccio E, Scaffa C, Raspagliesi F, Sismondi P, Biglia N.

Eur J Surg Oncol. 2014 Jul;40(7):891-8. doi: 10.1016/j.ejso.2013.11.026. Epub 2013 Dec 14.

PMID:
24378007
11.

Salvage cytoreductive surgery for recurrent endometrial cancer.

Bristow RE, Santillan A, Zahurak ML, Gardner GJ, Giuntoli RL 2nd, Armstrong DK.

Gynecol Oncol. 2006 Oct;103(1):281-7. Epub 2006 May 2.

PMID:
16631236
12.

Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery.

Benedetti Panici P, Perniola G, Angioli R, Zullo MA, Manci N, Palaia I, Bellati F, Plotti F, Calcagno M, Basile S.

Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1245-51. Epub 2007 Apr 8.

PMID:
17425680
13.

Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.

Zang RY, Zhang ZY, Li ZT, Cai SM, Tang MQ, Chen J, Liu Q.

Eur J Surg Oncol. 2000 Dec;26(8):798-804.

PMID:
11087649
14.

Secondary cytoreductive surgery for recurrent epithelial ovarian cancer.

Tay EH, Grant PT, Gebski V, Hacker NF.

Obstet Gynecol. 2002 Jun;99(6):1008-13.

PMID:
12052591
15.

Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.

Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY.

Gynecol Oncol. 1999 Mar;72(3):278-87.

PMID:
10053096
16.

Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study.

Eisenkop SM, Friedman RL, Wang HJ.

Cancer. 1995 Nov 1;76(9):1606-14.

17.

Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.

Chi DS, McCaughty K, Diaz JP, Huh J, Schwabenbauer S, Hummer AJ, Venkatraman ES, Aghajanian C, Sonoda Y, Abu-Rustum NR, Barakat RR.

Cancer. 2006 May 1;106(9):1933-9.

18.

Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.

Pavlov MJ, Kovacevic PA, Ceranic MS, Stamenkovic AB, Ivanovic AM, Kecmanovic DM.

Eur J Surg Oncol. 2009 Nov;35(11):1186-91. doi: 10.1016/j.ejso.2009.03.004. Epub 2009 Apr 8.

PMID:
19356887
19.

Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.

Vaccarello L, Rubin SC, Vlamis V, Wong G, Jones WB, Lewis JL, Hoskins WJ.

Gynecol Oncol. 1995 Apr;57(1):61-5.

PMID:
7705701
20.

Cytoreductive surgery for stage IV epithelial ovarian cancer.

Zang RY, Zhang ZY, Cai SM, Li ZT, Chen J, Tang MQ, Liu Q.

J Exp Clin Cancer Res. 1999 Dec;18(4):449-54.

PMID:
10746968

Supplemental Content

Support Center